Construction of Saccharopolyspora erythraea A226-SP mutant and analysis of its metabolic product

LIU Dao-Qin,HUANG Xun-Duan,KONG Xiao-Wei,MA Shu-Mei,LIU Hui,ZHANG Bu-Chang
DOI: https://doi.org/10.3969/j.issn.1674-9960.2009.03.007
2009-01-01
Abstract:Objective:To construct Saccharopolyspora erythraea mutant in order to explore the biosynthesis of the ketolide antibiotics.Methods:By reverse PCR,mutated DNA fragment SP in KR6 ketoreductase gene of S.erythraea was amplified,in which the sequence GGTGCG encoding Gly1141Ala1142 changed to AGCCCT encoding SerPro,and then subcloned to pWHM3 to construct homologous recombinant plasmid pWHM3-SP.Mediated by PEG,pWHM3-SP was transferred into S.erythraea A226 strain,and after two rounds of chromosomic homologous recombination,one mutant,named A226-SP,was screened out.Results:Sequencing results showed that the encoding sequence of Gly1141Ala1142 had changed into the sequence of SerPro in A226-SP chromosome,and the spectrum of HPLC-HRMS confirmed that A226-SP could synthesize 3-deoxy-3-oxo-erythrolide B(DOEB)and its intermediate product C18H34O6,but no erythromycin was found.Conclusion:Mutated Gly1141Ala1142 in KR6 ketoreductase could absolutely inactivate its function,and S.erythraea A226-SP mutant could biosynthesize ketolide compound DOEB.
What problem does this paper attempt to address?